SlideShare a Scribd company logo
Human bone marrow-derived
mesenchymal stem cells secrete
  brain-derived neurotrophic
    factor which promotes
   neuronal survival in vitro
                By
          Patel Devang V.
     M.S.Pharm (Pharmaceutics)
        NIPER-Ahmedabad
STEM CELLS
“Nonspecialized cells that have the capacity to self
  renew and to differentiate into specialized cells”
Stem cell type             Description                 Examples
           Stem cells can form only one type of Muscle stem
 Unipotent
           specialized cell type                   cells
                                                  Fetal tissue,
            Stem cells can form multiple types of
Multipotent                                        Adult stem
            cells and tissue types
                                                     cells
             Stem cells can form any adult cell type.
             However, they alone cannot develop into Blastocyst
 Pluripotent adult animal because they lack the (4 to 5 days
             potential to contribute to extraembryonic old embryo)
             tissue(such as the Placenta).

            Stem cells can differentiate into Cells from
            embryonic and extraembryonic cell early (1-3
 Totipotent
            types (eg. Placenta). Such cells can   days)
            construct a complete, viable organism embryo
• Embryonic Stem Cells can be obtained from
  blastocysts and aborted fetuses.
• Adult Stem Cells (Non-embryonic stem cells)
  have been found in the blood, bone
  marrow, liver, kidney, cornea, dental
  pulp, brain, skin, muscle, salivary gland etc.
MESENCHYMAL STEM CELLS(MSCs)
 • Morphologically, mesenchymal stem cells (MSCs)
   have long and thin cell bodies with a large
   nucleus.
 • Mesenchymal stem cells are a distinct entity to the
   mesenchyme (embryonic connective tissue which
   is derived from the mesoderm).
 • MSCs are adult stem cells found in the bone
   marrow, cord blood, peripheral blood, fallopian
   tube, fetal liver and lung.
 • MSCs have capacity to form multiple types of
   tissue         including      adipocytes        (fat
   cells), chondrocytes (cartilage cells), osteoblasts
   (bone cells), tendons, muscle, skin, neurons.
APPLICATIONS OF STEM CELLS
Stem cell therapy has the potential to treat many
  human diseases like:

•   Brain damage          • Diabetes
•   Leukemia              • Blindness and vision
•   Spinal cord injury      impairment
•   Heart damage          • Amyotrophic lateral
•   Muscle damage           sclerosis
•   Parkinson's disease   • Multiple sclerosis
•   Baldness              • Wound healing
•   Missing teeth         • Infertility
STEM CELLS IN NEUROLOGICAL
         DISEASES
                          In recent years,
                           there has been
       (A) Human ESCs      considerable
                           interest in the
                           potential of stem
                           cells as therapeutic
                           agents in
       (A) Neurons
                           neurological
           derived from
                           diseases including
           Human ESCs      stroke and spinal
                           cord injury.
• In neurological diseases it has been postulated that
  stem cell therapies may replace lost cells by
  differentiating into functional neural tissue; modulate
  the    immune        system     to   prevent     further
  neurodegeneration and effect repair; or provide a
  source of trophic support for the diseased nervous
  system.
Human bone marrow-derived
mesenchymal stem cells secrete brain-
  derived neurotrophic factor which
 promotes neuronal survival in vitro

                 Published In
      Stem Cell Research, 2009, 3, 63–70

                     By
           Alastair Wilkins et al.,
         Department of Neurology ,
           University of Bristol,
                    UK
AIM OF EXPERIMENT
• To define mechanisms of neuronal cell
  death under conditions of trophic
  deprivation and exposure to nitric oxide
• To determine potential mechanism by
  which human bone marrow-derived
  mesenchymal stem cells (MSCs) may
  protect neurons from trophic deprivation or
  NO-mediated damage
MATERIALS USED
• Neuronal cultures prepared from cortices of E16 rat embryos
• Bone marrow: Taken by the time of total hip replacement
  surgery by orthopedic surgeons at the Avon Orthopedic
  Centre, Bristol, UK
• Dulbecco's modified Eagles medium (DMEM) supplemented
  with 2% B27
• MIN (DMEM supplemented with chemically defined medium
  with no serum)
• CM (Mesenchymal stem cell-conditioned medium)
• Neuronal marker bisbenzamide
• DETANONOate (NO donor)
• LY290042 (PI3kinase/Akt inhibitor)
• Neutralising antibodies to BDNF
EXPERIMENT AND RESULT
[A] Determination of the influence of MSC-
  conditioned medium on signaling changes
  occurring during trophic factor withdrawal
• Cortical neurons (1.4 103 cells/mm2) were
  maintained in B27-supplemented Dulbecco's
  modified Eagles medium (DMEM).
• This was taken as Control throughout
  experiment and other values expressed as a
  percentage of this control.
• For determination of neuronal survival, cultures
  were fixed and stained by the nuclear marker
  bisbenzamide.
FIG : MSC-conditioned
                           medium increases
                           survival of neurons
                           exposed to trophic
                           deprivation


• MIN: Chemically defined medium with no serum
• CM: MSC-conditioned medium
• CM/LY: MSC-conditioned medium plus LY290042
FIG : MSC-conditioned
                                         medium increases
                                         survival of neurons
                                         exposed to trophic
                                         deprivation




• Neurons exposed to MIC (Chemically defined medium with no
  serum) showed decreased survival compared to control.
• Neurons exposed to CM (MSC-conditioned medium showed
  increased survival compared to those exposed to MIC (Chemically
  defined medium with no serum).
• The PI3 Kinase / Akt inhibitor LY290042 inhibits the survival effect of
  MSC-conditioned medium.
[B] Determination of the influence of MSC-conditioned
  medium on signaling changes occurring during NO
  exposure

                           FIG: MSC-conditioned medium
                             increases survival of neurons
                             exposed to nitric oxide

                           MIN: Chemically defined
                           medium with no serum

                           NO: DETANONOate

                           NO/CM: DETANONOate plus
                           MSC-conditioned medium

                           NO/CM/LY: DETANONOate
                           plus MSC-conditioned medium
                           plus LY290042
FIG: MSC-conditioned medium
                              increases survival of neurons
                              exposed to nitric oxide




• Neurons exposed to the DETANONOate (nitric oxide
  donor) showed decreased survival compared to
  control, a process which was attenuated by MSC-
  conditioned medium.
• The PI3 Kinase / Akt inhibitor LY290042 inhibits the
  survival effect of MSC-conditioned medium.
[C] Determination of the influence of MSC-conditioned
  medium on neuronal survival via PI3kinase/Akt-
  dependent pathways

                             FIG: MSC-conditioned
                               medium activates Akt in
                               neurons exposed to
                               trophic deprivation

 MIN: Chemically defined
 medium with no serum

 CM: MSC-conditioned
 medium

 CM/LY: MSC-conditioned
 medium plus LY290042
FIG: MSC-conditioned
                          medium activates Akt in
                          neurons exposed to
                          trophic deprivation


• Exposure of neurons to CM (MSC-
  conditioned medium) increased activation of
  Akt compared to those exposed to MIN
  (Chemically defined medium with no serum).
• Furthermore, addition of the PI3kinase/Akt
  inhibitor LY290042 inhibited CM (MSC
  conditioned medium)-induced survival of
  cortical neurons exposed to trophic factor
  withdrawal.
FIG: MSC-conditioned medium activates Akt in neurons
  exposed to DETANONOate


• B27: Neurons exposed to 2% B27
• MIN: Chemically defined medium with no serum
• NO: DETANONOate
• NO/CM: DETANONOate plus MSC-conditioned medium
• NO/CM/LY: DETANONOate plus MSC-conditioned
  medium plus LY290042
FIG: MSC-conditioned medium activates Akt in neurons
  exposed to DETANONOate
• Akt activation was seen in neurons exposed to
  CM (MSC-conditioned medium) in the presence
  of DETANONOate, compared to neurons
  exposed to DETANONOate alone.
• Furthermore, addition of the PI3kinase/Akt
  inhibitor LY290042 inhibited CM (MSC
  conditioned medium)-induced survival of cortical
  neurons exposed to NO exposure.
FIG: MSC-conditioned medium reduces p38 activation in
  neurons exposed to DETANONOate


• MIN: Chemically defined medium with no serum
• NO: DETANONOate
• NO/CM: DETANONOate plus MSC-conditioned
  medium
FIG: MSC-conditioned medium reduces p38 activation in
  neurons exposed to DETANONOate

• Furthermore exposure of neurons to MIN
  (Chemically defined medium with no serum) alone
  did not lead to activation of p38 MAPkinase, which
  occurred on exposure to DETANONOate.
• CM      (MSC-conditioned medium) attenuated
  DETANONOate-induced p38 activation within
  cortical neurons.
[D] Determination whether BDNF is important in
  mediating the MSC effects on neuronal survival

                         MIN: Chemically defined medium
                         with no serum

                         MSC1–6: Different MSC
                         populations (Derived from different
                         patients)

                         NeuronNO: Neurons exposed to
                         DETANONOate

                         BDNF        ELISA   demonstrated
FIG: Human MSCs          significant amounts of BDNF
                         secreted from MSCs.
  produce BDNF
FIG: Neutralising
  antibodies to BDNF
  attenuate MSC-
  conditioned medium
  survival effects under
  conditions of trophic
  deprivation

CM/aBDNF: MSC
 conditioned medium
 plus neutralising
 antibodies to BDNF
FIG: Neutralising antibodies
  to BDNF attenuate MSC
  conditioned medium
  survival effects under
  conditions of
  DETANONOate exposure

• NO/CM: DETANONOate
  plus MSC-conditioned
  medium
• NO/CM/aBDNF:
  DETANONOate plus MSC-
  conditioned medium plus
  neutralizing antibodies to
  BDNF
CONCLUSION
• Human        bone       marrow      derived
  mesenchymal stem cells secrete factors
  which protect rodent neurons from trophic
  deprivation and nitric oxide-induced death.
• Therefore human MSC transplantation has
  been shown to improve the outcome in a
  variety of neurological diseases including
  stroke and spinal cord injury.
REFERENCES
• Alastair Wilkins, Kevin Kemp et al., Human bone
  marrow-derived mesenchymal stem cells secrete
  brain-derived neurotrophic factor which promotes
  neuronal survival in vitro, Stem Cell Research, 2009,
  3, 63–70.
• Hokari M., Kuroda S., Shichinohe H. et al., Bone
  marrow stromal cells protect and repair damaged
  neurons     through     multiple    mechanisms,
  Neuroscience, 2008, 1024-1035.
• Rice C.M., Scolding N.J., Autologous bone marrow
  stem cells-properties and advantages, Neurological
  Science, 2008, 265, 59-62.
• Parr A.M. Tator C.H., Bone marrow-derived
  mesenchymal stromal cells for the repair of central
  nervous      system     injury,   Bone     Marrow
  Transplantation, 2008, 40, 609–619.
• Rosser A.E., Zietlow R., Dunnett S.B., Stem cell
  transplantation        for        neurodegenerative
  diseases, Curr. Opin. Neurol., 2007, 20, 688-692.
• http://www.nature.com/bmt/journal/v45/n8
• http://www.ncbi.nlm.nih.gov/pubmed/20028455#
• http://www.journal-inflammation.com/content/2/1/8
Stem cells in CNS disorders

More Related Content

What's hot

INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERINGINDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
harrisonjoshua
 
Stem cell research in Parkinson's Disease
Stem cell research  in Parkinson's DiseaseStem cell research  in Parkinson's Disease
Stem cell research in Parkinson's Disease
Veena Shriram
 
Stem Cell Therapy of Spinal Cord Injury
Stem Cell Therapy of Spinal Cord InjuryStem Cell Therapy of Spinal Cord Injury
Stem Cell Therapy of Spinal Cord Injury
wiseyou
 
Stem cell based therapies for diabetes
Stem cell based therapies for diabetesStem cell based therapies for diabetes
Stem cell based therapies for diabetes
Aman Kumar Naik
 
Neuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cellsNeuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cellsDiana Santos
 
hematology.wustl.edu/conferences/presentations/dip... hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/dip... 	 hematology.wustl.edu/...hematology.wustl.edu/conferences/presentations/dip... 	 hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/dip... hematology.wustl.edu/...MedicineAndHealthCancer
 
Stem cell in Neurosurgery
Stem cell in NeurosurgeryStem cell in Neurosurgery
Stem cell in Neurosurgery
Dr Fakir Mohan Sahu
 
Basics of cellular aging and
Basics of cellular aging andBasics of cellular aging and
Basics of cellular aging and
Dr. Mallappa Shalavadi
 
Pluripotent Stem Cells and their applications in disease modelling, drug disc...
Pluripotent Stem Cells and their applications in disease modelling, drug disc...Pluripotent Stem Cells and their applications in disease modelling, drug disc...
Pluripotent Stem Cells and their applications in disease modelling, drug disc...
tara singh rawat
 
Stem cell therapy in ENT
Stem cell therapy in ENTStem cell therapy in ENT
Stem cell therapy in ENT
SuryaR38
 
Dopaminergic cell replacement therapy in Parkinson disease by Siddhartha Das
Dopaminergic cell replacement therapy in Parkinson disease by Siddhartha DasDopaminergic cell replacement therapy in Parkinson disease by Siddhartha Das
Dopaminergic cell replacement therapy in Parkinson disease by Siddhartha Das
Siddhartha Das
 
Stem cells, A New Therapeutic Approach to Traumatic Brain Injury
Stem cells, A New Therapeutic Approach to Traumatic Brain InjuryStem cells, A New Therapeutic Approach to Traumatic Brain Injury
Stem cells, A New Therapeutic Approach to Traumatic Brain Injury
Reza Nejat, M.D., FCCM
 
Tissue engeneering dr quiyum
Tissue engeneering dr quiyumTissue engeneering dr quiyum
Tissue engeneering dr quiyum
MD Quiyumm
 
Restorative neurology
Restorative neurologyRestorative neurology
Restorative neurology
Professor Yasser Metwally
 
Neural Differentiation
Neural DifferentiationNeural Differentiation
Neural Differentiation
Amir Motmaen
 
Stem cells in cardiac care
Stem cells in cardiac careStem cells in cardiac care
Stem cells in cardiac care
BALASUBRAMANIAM IYER
 
Tissue engineering in the repair of spinal cord
Tissue engineering in the repair of spinal cordTissue engineering in the repair of spinal cord
Tissue engineering in the repair of spinal cord
Vharshini Manoharan
 
Stem cell therapy for spinal cord injuries
Stem cell therapy for spinal cord injuriesStem cell therapy for spinal cord injuries
Stem cell therapy for spinal cord injuries
Vishnu Ambareesh
 

What's hot (20)

INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERINGINDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
 
Stem cell research in Parkinson's Disease
Stem cell research  in Parkinson's DiseaseStem cell research  in Parkinson's Disease
Stem cell research in Parkinson's Disease
 
Stem Cell Therapy of Spinal Cord Injury
Stem Cell Therapy of Spinal Cord InjuryStem Cell Therapy of Spinal Cord Injury
Stem Cell Therapy of Spinal Cord Injury
 
Stem cell based therapies for diabetes
Stem cell based therapies for diabetesStem cell based therapies for diabetes
Stem cell based therapies for diabetes
 
Neuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cellsNeuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cells
 
7 ipsc 3:5:13
7 ipsc 3:5:137 ipsc 3:5:13
7 ipsc 3:5:13
 
hematology.wustl.edu/conferences/presentations/dip... hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/dip... 	 hematology.wustl.edu/...hematology.wustl.edu/conferences/presentations/dip... 	 hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/dip... hematology.wustl.edu/...
 
Stem cell in Neurosurgery
Stem cell in NeurosurgeryStem cell in Neurosurgery
Stem cell in Neurosurgery
 
Basics of cellular aging and
Basics of cellular aging andBasics of cellular aging and
Basics of cellular aging and
 
Pluripotent Stem Cells and their applications in disease modelling, drug disc...
Pluripotent Stem Cells and their applications in disease modelling, drug disc...Pluripotent Stem Cells and their applications in disease modelling, drug disc...
Pluripotent Stem Cells and their applications in disease modelling, drug disc...
 
Stem cell therapy in ENT
Stem cell therapy in ENTStem cell therapy in ENT
Stem cell therapy in ENT
 
Dopaminergic cell replacement therapy in Parkinson disease by Siddhartha Das
Dopaminergic cell replacement therapy in Parkinson disease by Siddhartha DasDopaminergic cell replacement therapy in Parkinson disease by Siddhartha Das
Dopaminergic cell replacement therapy in Parkinson disease by Siddhartha Das
 
Stem cells, A New Therapeutic Approach to Traumatic Brain Injury
Stem cells, A New Therapeutic Approach to Traumatic Brain InjuryStem cells, A New Therapeutic Approach to Traumatic Brain Injury
Stem cells, A New Therapeutic Approach to Traumatic Brain Injury
 
Tissue engeneering dr quiyum
Tissue engeneering dr quiyumTissue engeneering dr quiyum
Tissue engeneering dr quiyum
 
Restorative neurology
Restorative neurologyRestorative neurology
Restorative neurology
 
Neural Differentiation
Neural DifferentiationNeural Differentiation
Neural Differentiation
 
Stem cells in cardiac care
Stem cells in cardiac careStem cells in cardiac care
Stem cells in cardiac care
 
Tissue engineering in the repair of spinal cord
Tissue engineering in the repair of spinal cordTissue engineering in the repair of spinal cord
Tissue engineering in the repair of spinal cord
 
Stem cell Biobridge
Stem cell BiobridgeStem cell Biobridge
Stem cell Biobridge
 
Stem cell therapy for spinal cord injuries
Stem cell therapy for spinal cord injuriesStem cell therapy for spinal cord injuries
Stem cell therapy for spinal cord injuries
 

Viewers also liked

Approach to URTI
Approach to URTIApproach to URTI
PHC Primary Health Centre
PHC Primary Health CentrePHC Primary Health Centre
Chronic malnutrition
Chronic malnutritionChronic malnutrition
Pediatric tuberculosis
Pediatric tuberculosisPediatric tuberculosis
BPH, Prostate Cancer, Testicular Cancer
BPH, Prostate Cancer, Testicular CancerBPH, Prostate Cancer, Testicular Cancer
BPH, Prostate Cancer, Testicular CancerPatrick Carter
 
SAM
SAMSAM
Rda macro and micronutrients
Rda macro and micronutrientsRda macro and micronutrients
Hemophilia itp lymphoma
Hemophilia itp lymphomaHemophilia itp lymphoma
Contraception
ContraceptionContraception
ICTC
ICTCICTC
Psgn nephrotic syndrome
Psgn nephrotic syndromePsgn nephrotic syndrome

Viewers also liked (12)

Approach to URTI
Approach to URTIApproach to URTI
Approach to URTI
 
PHC Primary Health Centre
PHC Primary Health CentrePHC Primary Health Centre
PHC Primary Health Centre
 
Respiratory distress in newborn
Respiratory distress in newbornRespiratory distress in newborn
Respiratory distress in newborn
 
Chronic malnutrition
Chronic malnutritionChronic malnutrition
Chronic malnutrition
 
Pediatric tuberculosis
Pediatric tuberculosisPediatric tuberculosis
Pediatric tuberculosis
 
BPH, Prostate Cancer, Testicular Cancer
BPH, Prostate Cancer, Testicular CancerBPH, Prostate Cancer, Testicular Cancer
BPH, Prostate Cancer, Testicular Cancer
 
SAM
SAMSAM
SAM
 
Rda macro and micronutrients
Rda macro and micronutrientsRda macro and micronutrients
Rda macro and micronutrients
 
Hemophilia itp lymphoma
Hemophilia itp lymphomaHemophilia itp lymphoma
Hemophilia itp lymphoma
 
Contraception
ContraceptionContraception
Contraception
 
ICTC
ICTCICTC
ICTC
 
Psgn nephrotic syndrome
Psgn nephrotic syndromePsgn nephrotic syndrome
Psgn nephrotic syndrome
 

Similar to Stem cells in CNS disorders

Mesenchymal Stem Cells.pptx
Mesenchymal Stem Cells.pptxMesenchymal Stem Cells.pptx
Mesenchymal Stem Cells.pptx
SwapnaliBehera
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
Dr. Munish Kumar
 
Mesenchymal stemcells
Mesenchymal stemcellsMesenchymal stemcells
Mesenchymal stemcells
sharmilachandrapraka
 
S CdiferenciacióNpormatriz
S CdiferenciacióNpormatrizS CdiferenciacióNpormatriz
S CdiferenciacióNpormatrizroke
 
Exosomes -power point presentation
 Exosomes -power point presentation Exosomes -power point presentation
Exosomes -power point presentation
meghanamegha23
 
Stemcell Therapy in Neurosurgery
Stemcell Therapy in NeurosurgeryStemcell Therapy in Neurosurgery
Stemcell Therapy in Neurosurgery
PGINeurosurgery
 
Mitochondrial dna
Mitochondrial dnaMitochondrial dna
Mitochondrial dna
Alaa Al-Ruwaisan
 
Mitochondrial dna
Mitochondrial dna Mitochondrial dna
Mitochondrial dna
Alaa Al-Ruwaisan
 
Power 2
Power 2Power 2
Jaideep Sahni -Poster
Jaideep Sahni -PosterJaideep Sahni -Poster
Jaideep Sahni -PosterJaideep Sahni
 
Nanomedicina9
Nanomedicina9Nanomedicina9
Nanomedicina9
joanamatux
 
Apoptosis
ApoptosisApoptosis
Apoptosis
DR RML DELHI
 
Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017 Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017
maria414
 
Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017
maria414
 
physiology of apoptosis first year mbbs medical.pdf
physiology of apoptosis first year mbbs medical.pdfphysiology of apoptosis first year mbbs medical.pdf
physiology of apoptosis first year mbbs medical.pdf
DratoshKatiyar
 
Plegable- María José Cortés
Plegable- María José CortésPlegable- María José Cortés
Plegable- María José Cortés
maria414
 
Apoptosis seminar
Apoptosis seminarApoptosis seminar
Apoptosis seminar
Rajnish Mishra
 
EGR 183 Bow Tie Presentation
EGR 183 Bow Tie PresentationEGR 183 Bow Tie Presentation
EGR 183 Bow Tie Presentation
Joshua Mendoza-Elias
 
Muscle biopsy interpretation
Muscle biopsy interpretationMuscle biopsy interpretation
Muscle biopsy interpretation
MIMSR Medical college,Latur
 

Similar to Stem cells in CNS disorders (20)

Mesenchymal Stem Cells.pptx
Mesenchymal Stem Cells.pptxMesenchymal Stem Cells.pptx
Mesenchymal Stem Cells.pptx
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
 
Mesenchymal stemcells
Mesenchymal stemcellsMesenchymal stemcells
Mesenchymal stemcells
 
S CdiferenciacióNpormatriz
S CdiferenciacióNpormatrizS CdiferenciacióNpormatriz
S CdiferenciacióNpormatriz
 
1nanomedicine
1nanomedicine1nanomedicine
1nanomedicine
 
Exosomes -power point presentation
 Exosomes -power point presentation Exosomes -power point presentation
Exosomes -power point presentation
 
Stemcell Therapy in Neurosurgery
Stemcell Therapy in NeurosurgeryStemcell Therapy in Neurosurgery
Stemcell Therapy in Neurosurgery
 
Mitochondrial dna
Mitochondrial dnaMitochondrial dna
Mitochondrial dna
 
Mitochondrial dna
Mitochondrial dna Mitochondrial dna
Mitochondrial dna
 
Power 2
Power 2Power 2
Power 2
 
Jaideep Sahni -Poster
Jaideep Sahni -PosterJaideep Sahni -Poster
Jaideep Sahni -Poster
 
Nanomedicina9
Nanomedicina9Nanomedicina9
Nanomedicina9
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017 Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017
 
Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017Plegable María José Cortés Gaviria 2017
Plegable María José Cortés Gaviria 2017
 
physiology of apoptosis first year mbbs medical.pdf
physiology of apoptosis first year mbbs medical.pdfphysiology of apoptosis first year mbbs medical.pdf
physiology of apoptosis first year mbbs medical.pdf
 
Plegable- María José Cortés
Plegable- María José CortésPlegable- María José Cortés
Plegable- María José Cortés
 
Apoptosis seminar
Apoptosis seminarApoptosis seminar
Apoptosis seminar
 
EGR 183 Bow Tie Presentation
EGR 183 Bow Tie PresentationEGR 183 Bow Tie Presentation
EGR 183 Bow Tie Presentation
 
Muscle biopsy interpretation
Muscle biopsy interpretationMuscle biopsy interpretation
Muscle biopsy interpretation
 

Recently uploaded

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 

Recently uploaded (20)

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 

Stem cells in CNS disorders

  • 1. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro By Patel Devang V. M.S.Pharm (Pharmaceutics) NIPER-Ahmedabad
  • 2. STEM CELLS “Nonspecialized cells that have the capacity to self renew and to differentiate into specialized cells”
  • 3. Stem cell type Description Examples Stem cells can form only one type of Muscle stem Unipotent specialized cell type cells Fetal tissue, Stem cells can form multiple types of Multipotent Adult stem cells and tissue types cells Stem cells can form any adult cell type. However, they alone cannot develop into Blastocyst Pluripotent adult animal because they lack the (4 to 5 days potential to contribute to extraembryonic old embryo) tissue(such as the Placenta). Stem cells can differentiate into Cells from embryonic and extraembryonic cell early (1-3 Totipotent types (eg. Placenta). Such cells can days) construct a complete, viable organism embryo
  • 4. • Embryonic Stem Cells can be obtained from blastocysts and aborted fetuses. • Adult Stem Cells (Non-embryonic stem cells) have been found in the blood, bone marrow, liver, kidney, cornea, dental pulp, brain, skin, muscle, salivary gland etc.
  • 5. MESENCHYMAL STEM CELLS(MSCs) • Morphologically, mesenchymal stem cells (MSCs) have long and thin cell bodies with a large nucleus. • Mesenchymal stem cells are a distinct entity to the mesenchyme (embryonic connective tissue which is derived from the mesoderm). • MSCs are adult stem cells found in the bone marrow, cord blood, peripheral blood, fallopian tube, fetal liver and lung. • MSCs have capacity to form multiple types of tissue including adipocytes (fat cells), chondrocytes (cartilage cells), osteoblasts (bone cells), tendons, muscle, skin, neurons.
  • 6. APPLICATIONS OF STEM CELLS Stem cell therapy has the potential to treat many human diseases like: • Brain damage • Diabetes • Leukemia • Blindness and vision • Spinal cord injury impairment • Heart damage • Amyotrophic lateral • Muscle damage sclerosis • Parkinson's disease • Multiple sclerosis • Baldness • Wound healing • Missing teeth • Infertility
  • 7. STEM CELLS IN NEUROLOGICAL DISEASES In recent years, there has been (A) Human ESCs considerable interest in the potential of stem cells as therapeutic agents in (A) Neurons neurological derived from diseases including Human ESCs stroke and spinal cord injury.
  • 8. • In neurological diseases it has been postulated that stem cell therapies may replace lost cells by differentiating into functional neural tissue; modulate the immune system to prevent further neurodegeneration and effect repair; or provide a source of trophic support for the diseased nervous system.
  • 9. Human bone marrow-derived mesenchymal stem cells secrete brain- derived neurotrophic factor which promotes neuronal survival in vitro Published In Stem Cell Research, 2009, 3, 63–70 By Alastair Wilkins et al., Department of Neurology , University of Bristol, UK
  • 10. AIM OF EXPERIMENT • To define mechanisms of neuronal cell death under conditions of trophic deprivation and exposure to nitric oxide • To determine potential mechanism by which human bone marrow-derived mesenchymal stem cells (MSCs) may protect neurons from trophic deprivation or NO-mediated damage
  • 11. MATERIALS USED • Neuronal cultures prepared from cortices of E16 rat embryos • Bone marrow: Taken by the time of total hip replacement surgery by orthopedic surgeons at the Avon Orthopedic Centre, Bristol, UK • Dulbecco's modified Eagles medium (DMEM) supplemented with 2% B27 • MIN (DMEM supplemented with chemically defined medium with no serum) • CM (Mesenchymal stem cell-conditioned medium) • Neuronal marker bisbenzamide • DETANONOate (NO donor) • LY290042 (PI3kinase/Akt inhibitor) • Neutralising antibodies to BDNF
  • 12. EXPERIMENT AND RESULT [A] Determination of the influence of MSC- conditioned medium on signaling changes occurring during trophic factor withdrawal • Cortical neurons (1.4 103 cells/mm2) were maintained in B27-supplemented Dulbecco's modified Eagles medium (DMEM). • This was taken as Control throughout experiment and other values expressed as a percentage of this control. • For determination of neuronal survival, cultures were fixed and stained by the nuclear marker bisbenzamide.
  • 13. FIG : MSC-conditioned medium increases survival of neurons exposed to trophic deprivation • MIN: Chemically defined medium with no serum • CM: MSC-conditioned medium • CM/LY: MSC-conditioned medium plus LY290042
  • 14. FIG : MSC-conditioned medium increases survival of neurons exposed to trophic deprivation • Neurons exposed to MIC (Chemically defined medium with no serum) showed decreased survival compared to control. • Neurons exposed to CM (MSC-conditioned medium showed increased survival compared to those exposed to MIC (Chemically defined medium with no serum). • The PI3 Kinase / Akt inhibitor LY290042 inhibits the survival effect of MSC-conditioned medium.
  • 15. [B] Determination of the influence of MSC-conditioned medium on signaling changes occurring during NO exposure FIG: MSC-conditioned medium increases survival of neurons exposed to nitric oxide MIN: Chemically defined medium with no serum NO: DETANONOate NO/CM: DETANONOate plus MSC-conditioned medium NO/CM/LY: DETANONOate plus MSC-conditioned medium plus LY290042
  • 16. FIG: MSC-conditioned medium increases survival of neurons exposed to nitric oxide • Neurons exposed to the DETANONOate (nitric oxide donor) showed decreased survival compared to control, a process which was attenuated by MSC- conditioned medium. • The PI3 Kinase / Akt inhibitor LY290042 inhibits the survival effect of MSC-conditioned medium.
  • 17. [C] Determination of the influence of MSC-conditioned medium on neuronal survival via PI3kinase/Akt- dependent pathways FIG: MSC-conditioned medium activates Akt in neurons exposed to trophic deprivation MIN: Chemically defined medium with no serum CM: MSC-conditioned medium CM/LY: MSC-conditioned medium plus LY290042
  • 18. FIG: MSC-conditioned medium activates Akt in neurons exposed to trophic deprivation • Exposure of neurons to CM (MSC- conditioned medium) increased activation of Akt compared to those exposed to MIN (Chemically defined medium with no serum). • Furthermore, addition of the PI3kinase/Akt inhibitor LY290042 inhibited CM (MSC conditioned medium)-induced survival of cortical neurons exposed to trophic factor withdrawal.
  • 19. FIG: MSC-conditioned medium activates Akt in neurons exposed to DETANONOate • B27: Neurons exposed to 2% B27 • MIN: Chemically defined medium with no serum • NO: DETANONOate • NO/CM: DETANONOate plus MSC-conditioned medium • NO/CM/LY: DETANONOate plus MSC-conditioned medium plus LY290042
  • 20. FIG: MSC-conditioned medium activates Akt in neurons exposed to DETANONOate • Akt activation was seen in neurons exposed to CM (MSC-conditioned medium) in the presence of DETANONOate, compared to neurons exposed to DETANONOate alone. • Furthermore, addition of the PI3kinase/Akt inhibitor LY290042 inhibited CM (MSC conditioned medium)-induced survival of cortical neurons exposed to NO exposure.
  • 21. FIG: MSC-conditioned medium reduces p38 activation in neurons exposed to DETANONOate • MIN: Chemically defined medium with no serum • NO: DETANONOate • NO/CM: DETANONOate plus MSC-conditioned medium
  • 22. FIG: MSC-conditioned medium reduces p38 activation in neurons exposed to DETANONOate • Furthermore exposure of neurons to MIN (Chemically defined medium with no serum) alone did not lead to activation of p38 MAPkinase, which occurred on exposure to DETANONOate. • CM (MSC-conditioned medium) attenuated DETANONOate-induced p38 activation within cortical neurons.
  • 23. [D] Determination whether BDNF is important in mediating the MSC effects on neuronal survival MIN: Chemically defined medium with no serum MSC1–6: Different MSC populations (Derived from different patients) NeuronNO: Neurons exposed to DETANONOate BDNF ELISA demonstrated FIG: Human MSCs significant amounts of BDNF secreted from MSCs. produce BDNF
  • 24. FIG: Neutralising antibodies to BDNF attenuate MSC- conditioned medium survival effects under conditions of trophic deprivation CM/aBDNF: MSC conditioned medium plus neutralising antibodies to BDNF
  • 25. FIG: Neutralising antibodies to BDNF attenuate MSC conditioned medium survival effects under conditions of DETANONOate exposure • NO/CM: DETANONOate plus MSC-conditioned medium • NO/CM/aBDNF: DETANONOate plus MSC- conditioned medium plus neutralizing antibodies to BDNF
  • 26. CONCLUSION • Human bone marrow derived mesenchymal stem cells secrete factors which protect rodent neurons from trophic deprivation and nitric oxide-induced death. • Therefore human MSC transplantation has been shown to improve the outcome in a variety of neurological diseases including stroke and spinal cord injury.
  • 27. REFERENCES • Alastair Wilkins, Kevin Kemp et al., Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro, Stem Cell Research, 2009, 3, 63–70. • Hokari M., Kuroda S., Shichinohe H. et al., Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms, Neuroscience, 2008, 1024-1035. • Rice C.M., Scolding N.J., Autologous bone marrow stem cells-properties and advantages, Neurological Science, 2008, 265, 59-62.
  • 28. • Parr A.M. Tator C.H., Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury, Bone Marrow Transplantation, 2008, 40, 609–619. • Rosser A.E., Zietlow R., Dunnett S.B., Stem cell transplantation for neurodegenerative diseases, Curr. Opin. Neurol., 2007, 20, 688-692. • http://www.nature.com/bmt/journal/v45/n8 • http://www.ncbi.nlm.nih.gov/pubmed/20028455# • http://www.journal-inflammation.com/content/2/1/8